Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Corona Remedies acquires 7 Bayer brands, ahead of IPO
    17 July 2025

    Corona Remedies acquires 7 Bayer brands, ahead of IPO

    In a strategic move signaling its growing ambitions, Corona Remedies has acquired seven well-established pharmaceutical brands from Bayer’s Indian portfolio. The acquisition, effective July 16, 2025, includes one cardiology product and six widely used brands in the women’s health and fertility space.
  • 17 July 2025
    KRPA urges Health Minister to seek resignation of PCI President amid CBI probe
    The Karnataka Registered Pharmacists Association has officially requested the resignation of Dr. Montu Patel, President of the Pharmacy Council of India, in light of an ongoing CBI investigation into alleged misconduct.
  • 17 July 2025
    Nicox and Kowa inks up for USD 210.65 million for Glaucoma Treatment NCX 470 in U.S.
    Nicox SA, an international ophthalmology company, today announced the signing of a major new agreement concerning NCX 470 with Kowa Company, Ltd., a Japanese company with a global pharmaceutical business engaged in ground-breaking research, development and marketing.
  • 17 July 2025
    One drug offers hope for stroke patients

    Stroke is said to be the second leading cause of death worldwide after heart disease. To prevent the death of neurons in the brain, a research group led by Osaka Metropolitan University Associate Professor Hidemitsu Nakajima of the Graduate School of Veterinary Science has developed a drug that inhibits a protein involved in cell death.

  • 16 July 2025
    Breakthrough in Antibiotic Production : Scientists Unlock Genes to Mass-Produce Monensin
    In a significant step forward for industrial biotechnology, researchers have successfully engineered a bacterial strain capable of producing record-breaking levels of monensin, a widely used antibiotic in veterinary medicine and agriculture.
  • 16 July 2025
    FDA approves first interchangeable biosimilar insulin product to Novolog

    Today, the Food and Drug Administration approved, the first rapid-acting interchangeable biosimilar product, Kirsty (insulin aspart-xjhz), as a 3 mL single-patient-use prefilled pen and 10 mL multiple-dose vial. Kirsty is biosimilar to and interchangeable with Novolog (insulin aspart).

    Kirsty is a rapid-acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus.

  • 16 July 2025
    Sun Pharma launches LEQSELVI™ in the U.S. after patent settlement with Incyte
    Sun Pharmaceutical Industries Limited announced the official launch of LEQSELVI (deuruxolitinib tablets 8 mg) in the United States for the treatment of adults with severe alopecia areata
  • 16 July 2025
    Mouse study finds tirzepatide slowed obesity-associated breast cancer growth
    The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.
  • 12 July 2025
    Wockhardt to exit U.S. operations to prioritize innovation
    Indian pharmaceutical company Wockhardt has announced a significant strategic shift in its U.S. operations, marking a new chapter focused on innovation-led growth and portfolio rationalization. The company is phasing out its conventional U.S. generics business to channel efforts into high-value specialty products and innovative therapies.
  • 11 July 2025
    Glenmark and AbbVie sign USD 700 million drug licensing agreement
    AbbVie and IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), today announced an exclusive licensing agreement for IGIs lead investigational asset, ISB 2001, developed using IGIs proprietary BEAT protein platform, for oncology and autoimmune diseases
Subscribe to Pharma News